Sign inGet started

Miralles Gines Diego

Insider CIK 1773413 · NBSE Director · ARTV President & Head of R&D, Director · CTNM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
ARTV Artiva Biotherapeutics, In A Award2026-09-092026-09-1145,000— $0122,500SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
ARTV Artiva Biotherapeutics, In A Award2026-09-092026-09-1145,000— $0122,500SEC↗
CTNM Contineum Therapeutics, In A Award deriv2026-06-262026-06-2619,000— $019,000SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2026-05-182026-05-19232,500— $0232,500SEC↗
ARTV Artiva Biotherapeutics, In A Award2026-05-182026-05-1977,500— $077,500SEC↗
CTNM Contineum Therapeutics, In A Award deriv2025-06-262025-06-2614,750— $014,750SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
CTNM Contineum Therapeutics, In A Award deriv2025-03-142025-03-1729,500— $029,500SEC↗
NBSE NeuBase Therapeutics, Inc. A Award deriv2020-09-092020-09-1114,634— $014,634SEC↗
NBSE NeuBase Therapeutics, Inc. A Award deriv2019-07-122019-07-16227,330— $0227,330SEC↗